Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms

Saglio, Giuseppe;
2018-01-01

2018
67
67
74
www.elsevier.com/locate/leukres
CALR; Cardiotoxicity; CML; JAK2 inhibitors; Mastocytosis; MPN; TFR; Antineoplastic Agents; Calreticulin; Cardiovascular Diseases; Cell Transformation, Neoplastic; Chronic Disease; Congresses as Topic; Epigenesis, Genetic; Fusion Proteins, bcr-abl; Humans; Janus Kinase 2; Mastocytosis, Systemic; Mutation; Myeloproliferative Disorders; Protein Kinase Inhibitors; Remission Induction; Staurosporine; Translational Medical Research; Hematology; Oncology; Cancer Research
Mughal, Tariq I.*; Gotlib, Jason; Mesa, Ruben; Koschmieder, Steffen; Khoury, H. Jean; Cortes, Jorge E.; Barbui, Tiziano; Hehlmann, Rüdiger; Mauro, Mic...espandi
File in questo prodotto:
File Dimensione Formato  
paper3.docx

Accesso aperto

Tipo di file: PREPRINT (PRIMA BOZZA)
Dimensione 93.44 kB
Formato Microsoft Word XML
93.44 kB Microsoft Word XML Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1701793
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 9
social impact